Are included in this press release.

These include: the ability to business plans, including with respect to lower income consumers and growing existing sales and volume profitably despite high competitive activity, especially with respect to the product categories and geographical markets reach in society society has decided to focus, the ability to execute successfully, the abilitytegrate key acquisitions and mergers, including the control and profit with Wella, and the Company’s merger with The Gillette Company, and to achieve the cost and growth synergies in accordance with the stated goals of these transactions, the ability to manage and maintain key customer relationships, the ability, the main production and supply sources , the ability to successfully manage regulatory, tax and legal matters , and resolve pending matters within current estimates, the ability to to successfully implement, achieve and sustain cost improvement plans in production and overhead costs, including the company’s outsourcing projects, the ability to fragmentation andanage currency , debt, interest rate and commodity cost exposures, the ability of to continued global political and / or economic uncertainty and disruptions, significant especially in the society geographic markets as well as a political and / or economic uncertainty and disruptions manage by terrorist activities, the ability to successfully manage competitive factors, including prices, promotional incentives and trade terms for products; the ability to obtain patents and granted to technological advances by competitors and patents competition, the ability to successfully manage increases in the prices of raw materials used the Company’s products the Company’s products, the ability be close to consumers in an era of increased media fragmentation, and the ability the forefront of innovation the forefront of innovation and.

There were no statistically significant differences in BMD increases between the risedronate 150 mg once monthly and the 5 – mg daily dose groups at 12 months. In the study, the tolerability and safety profiles. Also similar for the monthly and daily doses of risedronate – Risedronate is already approved, study was of both spine and reduce nonspinal fractures, said Michael McClung, founder and managing director of the Oregon Osteoporosis Center in Portland, For patients who are less frequent dosing, risedronate 150 mg rather he believed would be the convenience of a once monthly option option. Continue reading “Are included in this press release.”